>

Stephen Doster

  • Vanderbilt University

    Roden honored with Oscar B. Hunter Career Award in Therapeutics

    Mar. 15, 2021, 9:26 AM   by Leigh MacMillan Dan Roden, MD Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, received the Oscar B. Hunter Career Award in Therapeutics last week at the virtual annual meeting of the American Society… Read More

    Mar. 16, 2021

  • Vanderbilt University

    New CRISPR screening technique developed at Vanderbilt leads to discovery of pathway that may be linked to cancer initiation

    by Marissa Shapiro Mar. 10, 2021, 9:00 AM A new genome-wide CRISPR screening technique conducted by researchers at Vanderbilt University is offering new insights about how tumors in 80 to 90 percent of all cancers grow. Maria Fomicheva Ian Macara (Vanderbilt University) This novel… Read More

    Mar. 10, 2021

  • Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. Dr. Crowe is the subject of a feature article in the upcoming Winter 2018 issue of Vanderbilt Magazine. Crowe, who is the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology, as well as director of the Vanderbilt Vaccine Center, has spent his career hunting for a universal flu vaccine. He has re-engineered how flu vaccines work and is on the edge of creating a single shot that covers all flu strains. In a new initiative announced in October, he will lead an international team of researchers as they launch clinical trials of his new vaccine.(John Russell/Vanderbilt University)

    Monoclonal antibody “cocktail” blocks COVID-19 variants: study

    Mar. 4, 2021, 11:19 AM   by Bill Snyder A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine. That was one… Read More

    Mar. 5, 2021

  • Vanderbilt University

    Chikungunya antibody identified by Crowe lab moves forward

    Mar. 4, 2021, 8:54 AM   by Bill Snyder Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center. This is the second monoclonal antibody against the debilitating tropical… Read More

    Mar. 4, 2021

  • Vanderbilt University

    Bordenstein elected to American Academy of Microbiology

    by Ann Marie Deer Owens Mar. 2, 2021, 5:30 PM Seth Bordenstein (Vanderbilt University) Seth Bordenstein, Centennial Professor of Biological Sciences, has been elected to fellowship in the American Academy of Microbiology, the honorific leadership group within one of the… Read More

    Mar. 3, 2021

  • Vanderbilt University

    Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

    by Marissa Shapiro Feb. 25, 2021, 8:00 AM A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Jerod Denton Craig Lindsley… Read More

    Feb. 26, 2021

  • Vanderbilt University

    Despite limitations of pandemic, research continues in Basic Sciences

    Feb. 24, 2021, 8:00 AM By Jenna Somers Vanderbilt researchers are prolific and resolute in their pursuit of transformative research and innovation. During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. On… Read More

    Feb. 24, 2021

  • Vanderbilt University

    Calcification after severe injury

    Feb. 23, 2021, 8:00 AM by Emily Stembridge Patients with severe injuries, such as level 1 trauma or burns, face many complications of calcification during recovery. One is loss of bone, or osteoporosis. Another is calcification of soft tissue, resulting in heterotopic… Read More

    Feb. 23, 2021

  • Vanderbilt University

    Christov & Westover Receive Research Staff Awards

    Research Staff Awards honor those who help drive engines of discovery Feb. 18, 2021, 9:57 AM   by Bill Snyder Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 17th annual Research Staff Awards, held virtually this year because of the… Read More

    Feb. 22, 2021

  • Vanderbilt University

    Genetic clues in eye birth defect

    Feb. 18, 2021, 11:00 AM by Leigh MacMillan Uveal coloboma can affect the iris — the colored part of the eye — giving it a keyhole appearance. (iStock) Uveal coloboma — a birth defect that causes a malformation of the eye — accounts for up to 10% of childhood blindness. Read More

    Feb. 18, 2021